Quantcast

Latest gabapentin Stories

Anticonvulsant Drug Helps Marijuana Smokers Kick The Habit
2012-04-24 10:40:34

Scientists at The Scripps Research Institute have found clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, helps people to quit smoking marijuana (cannabis). Unlike traditional addiction treatments, gabapentin targets stress systems in the brain that are activated by drug withdrawal. In a 12-week trial of 50 treatment-seeking cannabis users, those who took gabapentin used less cannabis, experienced fewer withdrawal symptoms such as...

e4ed0fb545995ffbe4138bdd0ac7c155
2011-06-29 05:45:00

A clinical trial of gabapentin, an epilepsy drug, may have been a "seeding trial" that was used by the pharmaceutical company purely for promotional purposes and to increase prescriptions, according to researchers from Yale School of Medicine. Joseph Ross, M.D. and his colleagues at Yale describe a seeding trial as "a clinical trial conducted primarily for marketing purposes and intended to promote the drug and increase prescribing by exposing physician-investigators to it." Researchers from...

2011-04-12 08:07:52

(Ivanhoe Newswire) -- The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain -- the burning or tingling pain in the hands and feet that affects millions of people with diabetes. Diabetic nerve pain, or neuropathy, is caused by nerve damage. "When neuropathy strikes, it is painful and can disrupt sleep; because of this, it can also lead to mood changes and lower quality of life," lead guideline author Vera Bril, MD, FRCP, with the...

2011-04-07 07:02:00

SILVER SPRING, Md., April 7, 2011 /PRNewswire-USNewswire/ -- On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets (gabapentin enacarbil), a once-daily treatment for moderate-to-severe restless legs syndrome (RLS). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) RLS is a disorder that causes a strong urge to move the legs. This urge often occurs with unpleasant feelings in the legs. People who have RLS describe feeling pulling, itching,...

2011-02-28 07:05:00

STAINES, England, February 28, 2011 /PRNewswire-FirstCall/ -- - Decision to Reimburse Qutenza(TM) (capsaicin 8% w/w dermal patch) by Sweden's Dental and Pharmaceutical Benefits Agency (Tand-och Lakemedelsformansverket) Gives new Option to Patients Living With Difficult-to-Treat Condition Patients in Sweden living with peripheral neuropathic pain are set to gain access to a new treatment option which can provide pain relief for up to three months following a single 30- or...

2011-02-28 06:00:00

PITTSBURGH, Feb. 28, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Gabapentin Capsules USP, 100 mg, 300 mg and 400 mg, the generic version of Pfizer's Neurontin(®) Capsules used to treat a painful complication of shingles. Gabapentin Capsules had U.S. sales of approximately $300...

2011-01-10 15:37:43

Most anti-epileptic drugs are associated with an increased risk of non-traumatic fracture in individuals 50 years of age and older, according to a report in the January issue of Archives of Neurology, one of the JAMA/Archives journals. Anti-epileptic drugs are considered a secondary risk factor for osteoporosis, according to background information in the article, because epilepsy is highly prevalent in older adults, a population already at risk for osteoporosis. Additionally, anti-epileptic...

2010-11-17 08:00:00

KANSAS CITY, Mo., Nov. 17, 2010 /PRNewswire/ -- Teva Neuroscience today announced the addition of an 11th member to Team COPAXONE® (glatiramer acetate injection); continuing a year-long celebration of the Team's 10 years of advocacy within the multiple sclerosis (MS) community. Jennifer Schuble, an elite track cyclist and member of the U.S. Paralympic Team, will join the Team's efforts in 2011 to promote a message of health and inspiration for those faced with an MS...

2010-10-06 07:00:00

BURLINGTON, Mass., Oct. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, although NeurogesX/Astellas's Qutenza is only approved for postherpetic neuralgia, surveyed U.S. physicians are likely to prescribe the drug for all neuropathic pain types. When asked to assume that patients suffering from other forms of neuropathic pain would be reimbursed for the cost of Qutenza treatment, 43 percent of...

2010-07-27 13:00:22

While the Food and Drug Administration (FDA) requires a warning of an increased risk of suicide for all epilepsy drugs, a new study shows that only certain drugs may increase the risk. The study is published in the July 27, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology. Newer drugs with a higher risk of causing depression than other epilepsy drugs, such as levetiracetam, topiramate and vigabatrin, were found to increase the risk of...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related